Thanks Carolyn for sharing your experiences in the CERE120 clinical trial. It might not necessarily be a bad thing that Ceregene annnouned its preliminary results so quickly. I read somewhere that if the results were good,the company was planning to move on to phase III as quickly as possible . But of course they were expecting different results. Hoping they will be further analyzing and releasing the data -- they might also find new information that could have an impact on the other gene therapy trials.